| Type I | | ALK1 (ACVRL1) | 
- Kinase inhibitors: K-02288
 
- ML-347 (LDN-193719, VU0469381)
  
- Other inhibitors: Disitertide
  
  | 
|---|
 | ALK2 (ACVR1A) | 
- Kinase inhibitors: DMH-1
 
- DMH-2
 
- Dorsomorphin (BML-275)
 
- K-02288
 
- ML-347 (LDN-193719, VU0469381)
  
  | 
|---|
 | ALK3 (BMPR1A) | 
- Kinase inhibitors: DMH-2
 
- Dorsomorphin (BML-275)
 
- K-02288
  
  | 
|---|
 | ALK4 (ACVR1B) | 
- Kinase inhibitors: A 83-01
 
- SB-431542
 
- SB-505124
  
  | 
|---|
 | ALK5 (TGFβR1) |  | 
|---|
 | ALK6 (BMPR1B) | 
- Agonists: BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
 
- Dibotermin alfa
 
- Eptotermin alfa
 
- GDF (5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 15)
 
- Radotermin
  
- Kinase inhibitors: DMH-2
 
- Dorsomorphin (BML-275)
 
- K-02288
  
  | 
|---|
 | ALK7 (ACVR1C) | 
- Kinase inhibitors: A 83-01
 
- SB-431542
 
- SB-505124
  
  | 
|---|
 
  | 
|---|
| Type II | | TGFβR2 | 
- Kinase inhibitors: DMH-2
 
- LY-364947
  
  | 
|---|
 | BMPR2 |  | 
|---|
 | ACVR2A (ACVR2) | 
- Agonists: Activin (A, B, AB)
 
- BMP (2, 4, 5, 6, 7, 8A, 8B, 15 (GDF9B))
 
- Dibotermin alfa
 
- Eptotermin alfa
 
- GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12), 9, 11 (BMP11), 15)
 
- Myostatin (GDF8)
 
- Nodal
 
- Radotermin
  
  | 
|---|
 | ACVR2B | 
- Agonists: Activin (A, B, AB)
 
- BMP (2, 4, 6, 7)
 
- Dibotermin alfa
 
- Eptotermin alfa
 
- GDF (1, 3, 5 (BMP14), 6 (BMP13), 7 (BMP12))
 
- Myostatin (GDF8)
 
- Nodal
 
- Osteogenin (BMP3, BMP3A)
 
- Radotermin
  
- Decoy receptors: Ramatercept
  
  | 
|---|
 | AMHR2 (AMHR) |  | 
|---|
 
  | 
|---|